A Chinese team has achieved a world first with a pig liver graft that functioned in a living recipient for more than a month, ...

DOR/ISL data presented show minimal changes in weight and body composition and no clinically meaningful effect on fasting lipids and the homeostatic model assessment of insulin resistance (HOMA-IR) ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that it will present new findings from its HIV treatment and prevention pipeline at the 20th European AIDS ...

About AL Amyloidosis AL amyloidosis is caused by abnormal plasma cells in the bone marrow, which produce misfolded amyloid proteins that build-up in the heart, kidney, and liver, causing heart and ...

On track for first FDA Biologics License Application (BLA) approved cell therapy in orphan indication relapsed/refractory AL Amyloidosis –Los ...

GC Biopharma USA, Inc., a leader in plasma-derived products, announced today that it will host a sponsored symposium and present two scientific posters at the 2025 Immunoglobulin National Society ...

NASHVILLE, TN / ACCESS Newswire / September 19, 2025 / In recognition of World Alzheimer's Day on September 21, MaxWell Clinic today announced that it is entering its eighth year of offering a ...

Renal Anhydramnios Fetal Therapy trial helps save life at Johns Hopkins NICU Center 2 dead, 8 injured in Michigan church shooting, fire. Here's what to know. 5 questions HR legally cannot ask you in a ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced its upcoming participation in the 20th European AIDS Conference (EACS) ...

The FDA has granted Fast Track designation to ABBV-CLS-628 for the treatment of autosomal dominant polycystic kidney disease.